Max Amor, MD

Commentary

2002 IAGS Proceedings: Intracranial Interventions (Part I of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

John Anderson: In the U.S. and in Australia, stroke is the third leading cause of death and the leading cause of disability. Yet despite this, there is an air of therapeutic nihilism about stroke. Patients who present to the emergency room...

John Anderson: In the U.S. and...

08/01/2008

Journal of Invasive Cardiology

Commentary

2002 IAGS Proceedings: Intracranial Intervention (Part II of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

Richard Myler: I have always believed that you don’t read history, you repeat it. You may never have heard about Richard Schneider who was the chief of Werner Forsmann in Germany. In 1929, a 24-year-old man who worked with Schneider had the...

Richard Myler: I have always...

08/01/2008

Journal of Invasive Cardiology

Feature

IAGS Proceedings - <br />
Troubling Lesion Subsets: Bifurcation Disease

08/01/2008

Brian O'Murchu , MD;

Howard A. Cohen , MD;

Hal Whitworth ;

Jeffrey Werner , MD;

Michael Cowley , MD;

Alfredo E. Rodriguez , MD, PhD;

James P. Zidar , MD;

Raoul Bonan , MD;

Kirk N. Garratt , MD, MSc;

Max Amor , MD;

Tom J. Linnemeier , MD;

Christopher U. Cates , MD;

Moderator: Kirk Garratt Panel Members: Tom Linnemeier, Brian O’Murchu, Jeffrey Werner Tom Linnemeier: The best treatment option today for a true LAD diagonal bifurcation lesion is to place a stent in the LAD and dilate through the...

Moderator: Kirk Garratt Panel...

08/01/2008

Journal of Invasive Cardiology

Paclitaxel Drug-Coated Balloon After Bare-Metal Stent Implantation, an Alternative Treatment to Drug-Eluting Stent in High Bleeding Risk Patients (The Panelux Trial)

03/28/2019

Christophe Piot , MD;

Jerome Roncalli , MD, PhD;

Matthieu Godin , MD;

Kamel Boughalem , MD;

John Shayne , MD;

Bruno Huret , MD;

Loic Belle , MD;

Max Amor , MD;

Benjamin Faurie , MD, PhD;

Bernard Karsenty , MD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...

Prolonged dual-antiplatelet...

03/28/2019

Journal of Invasive Cardiology